FDA Adverse Event Injury Summary report: N

VERCISE CARTESIA

MDR report key: 17159878 · Received June 19, 2023

Report

Report Number
3006630150-2023-03502
Event Type
Injury
Date Received
June 19, 2023
Date of Event
April 5, 2023
Report Date
August 28, 2023
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
NHL
UDI-DI
08714729905288
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

E1: PHONE NUMBER - (B)(6). ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: BRAND NAME: VERCISE CARTESIA, UPN: M365DB2202450, MODEL: DB-2202-45, SERIAL: (B)(6), BATCH: (B)(6).

Additional Manufacturer Narrative · 0

E1: PHONE NUMBER - (B)(6). ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: BRAND NAME: VERCISE CARTESIA, UPN: M365DB2202450, MODEL: DB-2202-45, SERIAL: (B)(6), BATCH: 7093420.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT THAT IS ENROLLED IN THE A4080 ESSENTIAL TREMOR REGISTRY CLINICAL TRIAL, EXPERIENCED A NON SERIOUS ADVERSE EVENT OF WOUND INFECTION AT THE LEAD SURGICAL SCAR SITE ON THE HEAD THAT WAS MODERATE IN SEVERITY. THE PATIENT WAS PRESCRIBED ANTIBIOTICS, WHICH CAUSED DIARRHEA AND THE EVENT RESOLVED TEN DAYS LATER. IT WAS NOTED THAT THE RELATIONSHIP OF THE EVENT WAS REPORTED AS HAVING A CAUSAL RELATIONSHIP TO THE PROCEDURE WHICH OCCURRED THREE MONTHS PRIOR, AND NOT RELATED TO THE DEVICE. THE DEVICES REMAIN IMPLANTED AND WILL THEREFORE NOT BE RETURNED FOR ANALYSIS. ADDITIONAL INFORMATION WAS RECEIVED THAT THE PATIENT ALSO EXPERIENCED PAIN AND SENSITIVITY TO THE TOUCH IN THE AREA OF THE RIGHT FRONTAL SCAR, AND THERE WAS SECRETION EXPRESSED FROM THE AREA. THE PATIENT WAS PLACED ON A COURSE OF ANTIBIOTICS FOR TEN DAYS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT THAT IS ENROLLED IN THE A4080 ESSENTIAL TREMOR REGISTRY CLINICAL TRIAL, EXPERIENCED A NON SERIOUS ADVERSE EVENT OF WOUND INFECTION AT THE LEAD SURGICAL SCAR SITE ON THE HEAD THAT WAS MODERATE IN SEVERITY. THE PATIENT WAS PRESCRIBED ANTIBIOTICS, WHICH CAUSED DIARRHEA AND THE EVENT RESOLVED TEN DAYS LATER. IT WAS NOTED THAT THE RELATIONSHIP OF THE EVENT WAS REPORTED AS HAVING A CAUSAL RELATIONSHIP TO THE PROCEDURE WHICH OCCURRED THREE MONTHS PRIOR, AND NOT RELATED TO THE DEVICE. THE DEVICES REMAIN IMPLANTED AND WILL THEREFORE NOT BE RETURNED FOR ANALYSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1014063 VERCISE CARTESIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS NHL BOSTON SCIENTIFIC NEUROMODULATION DB-2202-45 7093666 08714729905288

Patients

Seq Age Sex Outcome Treatment
1 66 YR Female Required Intervention